Free Trial

Nautilus Biotechnology (NAUT) Competitors

Nautilus Biotechnology logo
$0.83 +0.11 (+14.71%)
Closing price 03:59 PM Eastern
Extended Trading
$0.80 -0.03 (-3.75%)
As of 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NAUT vs. FEIM, QSI, QTRX, MASS, RPID, PRE, KEQU, OWLT, SEER, and INTT

Should you be buying Nautilus Biotechnology stock or one of its competitors? The main competitors of Nautilus Biotechnology include Frequency Electronics (FEIM), Quantum-Si (QSI), Quanterix (QTRX), 908 Devices (MASS), Rapid Micro Biosystems (RPID), Prenetics Global (PRE), Kewaunee Scientific (KEQU), Owlet (OWLT), Seer (SEER), and inTEST (INTT). These companies are all part of the "measuring and control equipment" industry.

Nautilus Biotechnology vs. Its Competitors

Nautilus Biotechnology (NASDAQ:NAUT) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Frequency Electronics has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nautilus BiotechnologyN/AN/A-$70.78M-$0.52-1.59
Frequency Electronics$69.81M4.16$23.69M$2.2913.00

Frequency Electronics has a net margin of 32.10% compared to Nautilus Biotechnology's net margin of 0.00%. Frequency Electronics' return on equity of 44.02% beat Nautilus Biotechnology's return on equity.

Company Net Margins Return on Equity Return on Assets
Nautilus BiotechnologyN/A -32.53% -27.85%
Frequency Electronics 32.10%44.02%25.07%

Nautilus Biotechnology currently has a consensus price target of $2.13, suggesting a potential upside of 157.26%. Frequency Electronics has a consensus price target of $43.00, suggesting a potential upside of 44.42%. Given Nautilus Biotechnology's higher possible upside, equities research analysts clearly believe Nautilus Biotechnology is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nautilus Biotechnology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Frequency Electronics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

50.7% of Nautilus Biotechnology shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 41.1% of Nautilus Biotechnology shares are held by insiders. Comparatively, 28.0% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Frequency Electronics had 5 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 7 mentions for Frequency Electronics and 2 mentions for Nautilus Biotechnology. Nautilus Biotechnology's average media sentiment score of 1.37 beat Frequency Electronics' score of 0.46 indicating that Nautilus Biotechnology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nautilus Biotechnology
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Frequency Electronics
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Nautilus Biotechnology has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Frequency Electronics has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500.

Summary

Frequency Electronics beats Nautilus Biotechnology on 11 of the 15 factors compared between the two stocks.

Get Nautilus Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAUT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAUT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAUT vs. The Competition

MetricNautilus BiotechnologyMED IndustryMedical SectorNASDAQ Exchange
Market Cap$104.33M$3.07B$5.65B$10.29B
Dividend YieldN/A2.36%5.68%4.61%
P/E Ratio-1.5920.7975.8626.14
Price / SalesN/A404.26515.95170.63
Price / CashN/A45.9137.5661.52
Price / Book0.509.6312.886.30
Net Income-$70.78M-$52.73M$3.29B$271.03M
7 Day Performance13.32%0.66%-0.24%-0.13%
1 Month Performance15.06%6.33%3.87%6.43%
1 Year Performance-70.71%18.99%68.39%28.82%

Nautilus Biotechnology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAUT
Nautilus Biotechnology
2.4322 of 5 stars
$0.83
+14.7%
$2.13
+157.3%
-76.2%$104.33MN/A-1.59130Positive News
High Trading Volume
FEIM
Frequency Electronics
3.3358 of 5 stars
$28.00
+3.2%
N/A+145.0%$264.50M$69.81M12.23200Gap Up
QSI
Quantum-Si
2.3293 of 5 stars
$1.26
+6.8%
$3.48
+175.8%
+72.1%$238.94M$3.06M-1.85150Trending News
Gap Down
QTRX
Quanterix
1.9023 of 5 stars
$4.97
+3.3%
$11.75
+136.4%
-61.8%$223.50M$137.42M-2.73460Positive News
MASS
908 Devices
1.7364 of 5 stars
$6.02
+7.5%
$8.00
+32.9%
+107.7%$215.88M$65.56M-11.1560Positive News
RPID
Rapid Micro Biosystems
3.3277 of 5 stars
$3.15
+4.0%
$8.00
+154.0%
+275.1%$133.74M$28.05M-3.12200High Trading Volume
PRE
Prenetics Global
1.0348 of 5 stars
$9.78
-2.9%
$9.00
-8.0%
+226.2%$130.82M$30.62M-2.451Positive News
KEQU
Kewaunee Scientific
0.871 of 5 stars
$45.30
+6.9%
N/A+30.4%$124.92M$240.47M10.971,239News Coverage
Gap Down
OWLT
Owlet
2.4617 of 5 stars
$6.96
+0.1%
$10.25
+47.4%
+95.2%$118.68M$78.10M-1.99106News Coverage
SEER
Seer
0.9033 of 5 stars
$2.04
-0.5%
N/A+29.3%$115.50M$14.17M-1.47160
INTT
inTEST
2.3394 of 5 stars
$7.21
-1.0%
$12.00
+66.4%
+25.7%$89.97M$121.64M31.35320

Related Companies and Tools


This page (NASDAQ:NAUT) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners